Coagulation disorders associated with cerebral venous thrombosis;Thrombophilies et thromboses veineuses cérébrales

Revue Neurologique

Volumn 158, Issue 5 I, 2002, Pages 543-552

  Schluck E ^a   Rodier, G ^a   Derouiche, F ^a   Bronner, P ^a   Boulay, C ^a   Courtois, S ^a   Cohen, E ^a  

^a Hôpitaux Universitaires de Strasbourg   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ACTIVATED PROTEIN C RESISTANCE; ANTIPHOSPHOLIPID SYNDROME; ANTITHROMBIN III DEFICIENCY; BLOOD CLOTTING DISORDER; BRAIN VEIN; HUMAN; PREGNANCY; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; PUERPERIUM; REVIEW; RISK FACTOR; VEIN THROMBOSIS;

3' UNTRANSLATED REGIONS; ACTIVATED PROTEIN C RESISTANCE; AFIBRINOGENEMIA; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; ANTITHROMBIN III DEFICIENCY; AUTOIMMUNE DISEASES; CEREBRAL VEINS; FACTOR V; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTRACRANIAL THROMBOSIS; PLASMINOGEN; POINT MUTATION; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; PROTHROMBIN; RISK FACTORS; THROMBOMODULIN; THROMBOPHILIA;

EID: 0036104075     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (94)

1. Fatal cerebral venous thrombosis as the initial manifestation of the antiphospho-lip syndrome
2. Anomalies constitutionnelles de la coagulation prédisposant à la thrombose
3. Protein C and protein S deficiencies
4. Thrombosis of the deep cerebral veins with excessive bilateral infarction in a premature infant with the thrombogenic 4G/4G genotype of the plasminogen activator inhibitor-1
5. Le risque vasculaire des contraceptifs oraux: Réalité et mécanisme. Mécanismes des accidents vasculaires: Leur prévention
6. Association dysfibrinogénémie et thrombose. À propos d'une famille (Fibrino-gène Melun) et revue de la littérature
7. Mutation in blood coagulation factor V associated with resistance to activated protein C
8. Frequency of the 20210 G → A mutation in the 3'-untranslated region of the prothrombin gene in 35 cases of cerebral venous thrombosis
9. Cerebral venous sinus thrombosis and antiphospholipid antibodies
10. Thrombophlébite cérébrale, phlébite surale, embolies pulmonaires et déficits en protéine S
11. Superior sagittal sinus thrombosis occuring at high altitude associated with protein C deficiency
12. Cerebral venous thrombosis - A review of 38 cases
13. Cerebral venous thrombosis. Role of activated protein C resistance and factor V gene mutation
14. The hypercoagulable state. Who, how, and when to test and treat
15. Cerebral venous thrombosis and anticardiolipin antibodies
16. Frequency of the G 20210 A mutation in the 3'untranslated region of the prothrombin gene in 35 patients with cerebral venous thrombosis
17. Thrombophilie multigénétique: Anomalie génétique du facteur II et mutation du facteur V Leiden
18. Congenital protein C deficiency and superior sagittal sinus thrombosis causing isolated intracranial hypertension
19. Superior sagittal sinus thrombosis in a patient with protein S deficiency
20. Antibodies to tissue-type plasminogen activator in plasma from patients with primary antiphospholipid syndrome
21. Resistance to activated protein C as risk factor for thrombosis: Molecular mechanisms, laboratory investigation and clinical management
22. Cerebral venous thrombosis in adults. A study of 40 cases from Saudi Arabia
23. Case-control study of risk of cerebral sinus thrombosis in oral contraceptive users who are carriers of hereditary prothrombotic conditions
24. Place du laboratoire d'hémostase dans la démarche étiologique des thromboses veineuses profondes
25. Postpartum cerebral venous thrombosis, congenital protein C deficiency and activated protein C resistance due to heterozygous factor V Leiden mutation
26. Inherited thrombophilia: Pathogenesis, clinical syndromes and management
27. Coagulation studies, factor V Leiden and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis
28. Syndrome des anticorps antiphospholipides
29. Superior sagittal sinus thrombosis and acquired free protein S deficiency in the elderly
30. Cerebral venous thrombosis and activated protein C resistance
31. Thrombophlébite cérébrale du post-partum. Un cas secondaire à un déficit acquis en antithrombine III
32. L'intrication des facteurs de risque dans la maladie thromboembolique veineuse
33. Cerebral venous thrombosis: New causes for an old syndrome?
34. Déficit en protéine C et thrombose veineuse cérébrale au cours de la grossesse
35. Free protein S deficiency is a risk factor for venous thrombosis
36. Anticardiolipin antibodies and the risk of ischemic stroke and venous thrombosis
37. Protein S deficiency in middle-aged women with stroke
38. Manifestations neurologiques associées aux anticorps antiphospholipides. Ou que reste t-il du neurolupus?
39. Thrombophlébite cérébrale révélatrice d'un déficit fonctionnel en protéine C
40. Cerebral sinus thrombosis in a patient with hereditary protein S deficiency: Case report and review of the literature
41. Protéine C et implications cliniques
42. G 20210 A prothrombin gene mutation in two siblings with cerebral venous thrombosis
43. Heterozygous protein C deficiency: A propos of 2 cases with cerebral venous thrombosis in the neonatal period
44. Intracranial venous and dural sinus thrombosis due to protein S deficiency in a patient with AIDS
45. Cerebral venous sinus thrombosis associated with G 20210 A mutation of the prothrombin gene
46. Cerebral venous thrombosis and chronic active hepatitis as part of the anti-phospholipid syndrome
47. Cerebral venous sinus thrombosis associated with factor V gene mutation
48. Superior sagittal sinus and cerebral cortical venous thrombosis caused by congenital protein C deficiency-case report
49. Inherited thrombophilia
50. Cerebral venous thrombosis and procoagulant factors: A case study
51. Cerebral venous thrombosis with lupus anticoagulants: Report of two cases
52. Combined heterozygosity of factor V leiden and the G20210A prothrombin gene mutation in a patient with cerebral cortical vein thrombosis
53. Antiphospholipid antibodies: Anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders
54. Factor V Leiden mutation is a risk factor for cerebral venous thrombosis. A case-control study of 55 patients
55. Thrombophlébite cérébrale du post-partum révélatrice d'un déficit congéni-tal en protéine C
56. Neurology and the blood: Haematological abnormalities in ischaemic stroke
57. Factor V gene mutation is a risk factor for cerebral venous thrombosis
58. High risk of cerebral vein thrombosis in carriers of a prothrombin gene mutation and in users of oral contraceptives
59. Acquired APC resistance related to oral contraceptives and pregnancy and its possible implications for clinical practice
60. Antithrombin III concentrates
61. Thromboses veineuses cérébrales
62. Inherited predisposition to thrombosis
63. Pseudotumor syndrome associated with cerebral venous sinus occlusion and antiphospholipid antibodies
64. Thromboses veineuses cérébrales à l'lle de la Réunion. Une série de 20 patients
65. A novel thrombomodulin gene mutation in a patient suffering from sagittal sinus thrombosis
66. Electric injury with cerebral venous thrombosis. Case report and review of the literature
67. Manifestations neurologiques du syndrome des antiphospholipides
68. Syndrome des antiphospholipides
69. A common genetic variation in the 3'untranslated region of the prothrombin gene is associated with elevated pasma prothrombin levels and an increase in venous thrombosis
70. A critical review of the evidence supporting a relationship between impaired fibrinolytic activity and venous thromboembolism
71. Prothrombin gene G 20210 A transition is a risk factor for cerebral venous thrombosis
72. Cerebral and vein thrombosis, transient protein S deficiency and cardiolin antibodies
73. Risk factors for venous thrombosis: Prevalence, risk, and interaction
74. Anticoagulants circulants, antiphospholipides et thromboses
75. Thrombophlébite cérébelleuse chez un homme porteur d'un déficit familial en antithrombine III
76. Cerebral venous thrombosis with plasminogen deficiency
77. Cerebral venous thrombosis and the G 20210 A mutation of factor II
78. Inherited protein deficiency, factor V G 1691 and FV A 4070 G mutations in a child with internal cerebral venous thrombosis
79. Thrombose veineuse cérébrale et déficit en protéine S. À propos de deux cas
80. Screening for thrombophilic risk factors among 25 German patients with cerebral venous thrombosis
81. Homozygous protein C deficiency in a newborn
82. Deep cerebral venous thrombosis and hereditary tissue plasminogen activa-tor (t-PA) deficiency
83. Cerebral vein thrombosis due to hereditary antithrombin III deficiency
84. Incrased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation
85. Cerebral venous thrombosis in systemic lupus erythematosus
86. Cerebral venous thrombosis in hereditary protein C deficiency
87. Aspects physiopathologiques des thromboses cérébrales veineuses et sinusales
88. Isolated cortical vein thrombosis and activated protein C resistance
89. Coincidence of factor V Leiden mutation and a mutation in the prothrombin gene at position 20210 in a patient with puerperal cerebral venous throm-bosis
90. Incrased rate of factor V Leiden mutation in patients with cerebral venous thrombosis
91. Hereditary thrombophilia in cerebral venous thrombosis
92. Cerebral haemorrhagic infarction in young patients with hereditary protein C deficiency: Evidence for spontaneous cerebral venous thrombosis
93. Factor V Leiden mutation in cerebral venous thrombosis